Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Psoriasis Market and Forecast Analysis to 2025” drug pipelines has been added to ResearchAndMarkets.com’s offering. Psoriasis is a…
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today
announced the launch of a generic version of Tracleer®1
(bosentan) tablets, 62.5 mg and 125 mg, in the U.S.
The program facilitated by Johnson & Johnson Innovation will recruit data scientists to research high impact, data-science projects in healthcare…
BERWYN, Pa.–(BUSINESS WIRE)–AscellaHealth, a national Pharmacy Benefit Management (PBM) serving commercial, Medicare and Medicaid segments, is proud to announce that…
A recognized scientific informatics pioneer, Mr. Conway brings to Riffyn extensive experience transforming scientific data environments and analytics OAKLAND, Calif.–(BUSINESS…
VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. (NYSE/TSX:ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics (the “Company”), announced today the pricing of…
Prevail Therapeutics Inc. (Nasdaq: PRVL) (Prevail), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative disorders, today announced the pricing of its initial public offering of 7,353,000 shares of its common stock at a price to the public of $17.00 per share.
IASO Biotherapeutics unveils an innovative new CAR-T therapy for the treatment of relapse/refractory multiple myeloma and the retreatment of previously…
DUBLIN–(BUSINESS WIRE)–The “Global Immunotherapy Drugs Market – Drivers, Restraints, Opportunities, Trends, and Forecast up to 2025” report has been added…
Glaukos will establish a new R&D retinal program that
complements our growing glaucoma franchise and pipeline.